改善喉切除术患者的语音质量,使用肉毒素A毒素
Gonçalo Caetano1, Filipa Morgado2, Joana Póvoa3
1Hospital da Senhora da Oliveira, Guimarães, Portugal.
Acta otorrinolaringologica espanola
|March 22, 2025
概括
毒素A注射改善了喉切除术后85%的患者的气管食管 (TEP) 语音. 这种安全有效的治疗方法为语音康复提供了一个可行的替代方案.
科学领域:
- 耳鼻喉科 耳鼻喉科 耳鼻喉科
- 语音语言病理学 语言病理学
- 再生医学是一种再生医学.
背景情况:
- 气管食管 (TEP) 语音是喉切除术后的主要语音康复方法.
- 胃食道的高性常常阻碍了成功的TEP演讲.
- 毒素A (BTA) 提供了一个非外科手术的选择,用于喉肌肉消.
研究的目的:
- 评估毒素A (BTA) 注射用于语音康复的有效性.
- 评估BTA注射在治疗TEP失败后喉切除术后言语患者的安全性.
主要方法:
- 20名失败TEP语音患者的回顾性队列研究 (2019-2023年).
- 胃食道部分BTA注射 (6个部位的100个单位).
- 在注射前和注射后的感知语音质量评级,使用7分级.
主要成果:
- 语音质量的显著改善 (2.05至4.55,P=.004).
- 85%的患者经历了TEP语音质量的改善.
- 60%的声音评级达到好到优秀;没有报告的不良影响.
结论:
- 注射BTA是一种安全有效的方法来改善TEP语音.
- 大多数患者在术后表现出语音质量的提高.
相关概念视频
Larynx
1.1K
The human larynx, often referred to as the voice box, is an intricate organ located in the neck. It serves as a pathway for air to enter the lungs during respiration and is an essential component of voice production.
Anatomy of the Larynx
The larynx consists of various components, including cartilage, muscles, and vocal cords. Its structure includes three large unpaired cartilages—the thyroid, cricoid, and epiglottis—and three smaller paired cartilages—the arytenoids,...
Anatomy of the Larynx
The larynx consists of various components, including cartilage, muscles, and vocal cords. Its structure includes three large unpaired cartilages—the thyroid, cricoid, and epiglottis—and three smaller paired cartilages—the arytenoids,...
1.1K
Skeletal Muscle Relaxants: Therapeutic Uses
448
Skeletal muscle relaxants are used to relax muscle tone and alleviate painful muscle contractions. However, the choice of skeletal muscle relaxants depends on the duration of the surgical procedure in order to minimize potential side effects. Skeletal muscle relaxants like neuromuscular blocking agents [NMBAs] are commonly employed as adjuvants alongside general anesthetics in clinical settings. NMBAs are also used to maintain controlled ventilation during surgery of the larynx or pharynx...
448
Myasthenia Gravis: Overview and Treatment
1.1K
Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
1.1K


